Product Details
| Product Name:
FR900359 |
CAS No.:
107530-18-7 |
| Supply Ability:
10g |
Release date:
2026/07/27 |
Product Introduction
Bioactivity
| Name | FR900359 |
| Description | FR900359, a non-ribosomal cyclic peptide derived from the soil bacterium Chromobacterium oxysporum, is a macrocyclic Gq protein inhibitor that inhibits melanoma cell proliferation and can be used in studies of asthma, inflammation, and cancer. |
| In vitro | FR900359 (0-10 μM; treated for 24 hours) effectively reduces the growth of B16 cells in a concentration-dependent manner, inhibiting cell proliferation and migration[1]. |
| In vivo | In isometric force measurements in the mouse tail artery, FR900359 (1.0 μM; post-wash) significantly reduces vascular tone[1]. |
| Storage | Store at low temperature
Pure form: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | FR900359 | ERK | Apoptosis |
| Inhibitors Related | Stavudine | Aceglutamide | Urea | Tamoxifen | L-Cysteine | Metronidazole | Formamide | Gluconate Calcium | Dimethyl phthalate | Alginic acid | Dextran sulfate sodium salt (MW 5000) | Sildenafil citrate |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
|
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States